BPA
BIIB icon

Beacon Pointe Advisors’s Biogen BIIB Stock Holding History

Beacon Pointe Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$981K Buy
4,544
+461
+11% +$88.2K ﹤0.01% 1046
2026
Q1 		$749K Buy
4,083
+682
+20% +$126K ﹤0.01% 1106
2025
Q4 		$598K Buy
3,401
+177
+5% +$28.9K ﹤0.01% 1014
2025
Q3 		$452K Buy
+3,224
New +$436K ﹤0.01% 1040
2025
Q1 		– Sell
-1,537
Closed -$235K – 1219
2024
Q4 		$235K Buy
1,537
+149
+11% +$25.1K ﹤0.01% 1096
2024
Q3 		$269K Sell
1,388
-285
-17% -$59.6K ﹤0.01% 1063
2024
Q2 		$388K Sell
1,673
-2,606
-61% -$566K ﹤0.01% 962
2024
Q1 		$923K Sell
4,279
-263
-6% -$61.6K 0.01% 716
2023
Q4 		$1.18M Sell
4,542
-13,614
-75% -$3.34M 0.01% 620
2023
Q3 		$4.67M Buy
18,156
+16,806
+1,245% +$4.5M 0.06% 284
2023
Q2 		$385K Buy
1,350
+82
+6% +$24.4K 0.01% 800
2023
Q1 		$353K Sell
1,268
-271
-18% -$75K 0.01% 871
2022
Q4 		$426K Buy
1,539
+271
+21% +$76.5K 0.01% 745
2022
Q3 		$341K Buy
1,268
+12
+1% +$2.55K 0.01% 761
2022
Q2 		$255K Sell
1,256
-12,207
-91% -$2.5M 0.01% 884
2022
Q1 		$2.83M Buy
13,463
+10,369
+335% +$2.25M 0.04% 372
2021
Q4 		$742K Buy
3,094
+1,003
+48% +$258K 0.02% 447
2021
Q3 		$592K Sell
2,091
-655
-24% -$215K 0.01% 508
2021
Q2 		$951K Buy
2,746
+1,766
+180% +$535K 0.03% 347
2021
Q1 		$271K Buy
+980
New +$264K 0.02% 411
2019
Q2 		– Sell
-7,472
Closed -$1.76M – 205
2019
Q1 		$1.76M Buy
+7,472
New +$2.35M 0.66% 46

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beacon Pointe Advisors's BIIB Position: Q2 2026 in Review

Beacon Pointe Advisors increased its Biogen (BIIB) stake by 11% in Q2 2026, buying an estimated $88.2K and bringing the position to 4,544 shares worth $981K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Beacon Pointe Advisors first reported a position in BIIB in Q1 2019 and has held it in 21 quarters since. The position peaked at $4.67M in Q3 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Beacon Pointe Advisors held 4,544 shares of Biogen worth $981K as of Q2 2026.
  • Beacon Pointe Advisors bought 461 Biogen shares in Q2 2026, an estimated $88.2K.
  • Biogen made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #1046 holding.
  • Beacon Pointe Advisors first reported a position in Biogen in Q1 2019 and has held it in 21 quarters since.
  • Beacon Pointe Advisors's Biogen position peaked at $4.67M in Q3 2023.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.